Page 25 - Tata Chemical Annual Report_2022-2023
P. 25
Integrated Annual Report 2022-23 01-83 84-192 193-365
Integrated Report Statutory Reports Financial Statements
Specialty Products Business
Value Chain
Fermentation Prebiotics
At Tata Chemicals, our prebiotics Business Overview
portfolio division, under the brand During the year, we continued the growth journey despite
name Tata NQ, leverages the advances challenging business environment. We consolidated our
in precision fermentation to offer position in existing customer segments and developed Raw materials Processing Products Packaging
specialised, nature-inspired and newer segments. Sucrose Bio transformation FOS - short chain Jerry can
science-backed ingredients and Microorganisms fructooligosaccharide Pails
formulations for human and animal Growth media IBC (Intermediate
nutrition. Bulk Container)
Existing Segments New Segments
Paper bags
Scaling the Health Quotient We added several new We continued to
key accounts, from whom progress on the
Our flagship product - FOSSENCE® is short we are receiving repeat development of
chain Fructooligosaccharides, commonly orders – an endorsement formulations designed
referred to as FOS or oligofructose. of the quality of our to replace sugar, while
products, services and
maintaining the taste
Manufactured using precision customer delight and texture profiles of End use Distribution Logistics
fermentation of sucrose at our state- the final product
of-the-art facility in Mambattu, Andhra While existing distributors We witnessed opening Infant nutrition Direct engagement with Road
enhanced their reach
Pradesh, it finds application in food and through better coverage up of the animal Food & beverages key accounts Sea
beverage formulations, infant nutrition, initiatives, new territories nutrition segment with Dietary supplements Network of distributors Air
nutraceuticals and in animal nutrition. Our were opened with the commencement Animal nutrition Warehousing at multiple
Mambattu facility is FSSC22000-certified the appointment of of exports in the feed locations
and IGBC gold-rated. additional channel segment in South East
partners Asia
We have a multi-disciplinary team of
scientists working on microbiome
science (the core science platform)
and fermentation technology (the The business showed strong growth on the back
of increasing short chain Fructooligosaccharide
manufacturing platform).
demand, and focussed application development
efforts. The Global industry is estimated to be
growing at 7.5-10% CAGR, with higher growth rate
in certain markets.
Location: Mambattu Plant
22 23
